Progressnotes Year-In-Review 2015
Strong Solutions Quality
Discovering new ways to strengthen patient safety and quality is an expectation of every member of the MUSC Health team. In 2015, infection control experts succeeded in reducing infection rates, clinicians built more evidence-based practices into Epic electronic medical records, and managers adopted a business-world methodology that leads to controlling costs. For many years, MUSC Health has been building a nursing culture that engages nurses and involves them in organizational decision-making.
In 2015, the American Nurses Credentialing Center recognized that culture with Magnet® designation. A Gallup survey estimates that Magnet® hospitals experience 7.1 percent fewer safety-related incidents than the industry norm. Culture and commitment come together at MUSC Health for strong solutions, strong lives.
Year in Review 2015 Quality
In September 2015, MUSC Health received the ultimate credential for high-quality nursing care when awarded with Magnet Recognition.
Anton Gunn, Executive Director of Community Health & Chief Diversity Officer, is responsible for nurturing diversity-awareness at MUSC Health.
Infection Control Wins
MUSC Health operates on the principles of: leadership engagement, process improvement, and a culture of safety.
Innovations in the Clinic
Innovation reaching the clinic in 2015 thanks to MUSC Health clinician/researchers includes new drugs for heart failure and cystic fibrosis; new medical devices such as the first MRI-safe implantable cardioverter-defibrillator and a novel spinal surgery rod; and a diagnostic tool that will remove the ambiguity from lung cancer diagnosis. Clinical trials at MUSC Health are setting the standards for care nationwide and offering patients in the region access to revolutionary cancer treatments, including precision therapy and immunotherapy, as well as novel treatments for many other diseases, such as a thermosensitive gel for Menière’s disease and a gene therapy for sickle cell disease. New centers are fostering a culture of innovation and helping translate that innovation into improved patient care.
Year in Review 2015 Innovation
Heart Failure Patients
The summer of 2015 saw approval of the first new drug for heart failure (HF) in almost two decades.
Next Generation Devices
MUSC Health cardiologist Michael Gold, MD, has been key in introducing implantable cardioverter-defibrillator innovations.
MUSC Health’s Division of Neuroendovascular Surgery has earned an international reputation for advancing intra-arterial therapies for ischemic stroke.
Advances for Healthy Lungs
Clinical trials conducted at MUSC and other sites that studied the efficacy of therapies for cystic fibrosis (CF) have revealed a winning two-drug combination.
Preventing Pulmonary Embolism
MUSC was awarded $13.5 million by the Patient-Centered Outcomes Research Institute (PCORI) to conduct a 25-site trial.
Culture of Innovation
Innovation is an essential survival tool for medical institutions as models of care and reimbursement undergo rapid change.
In 2015, MUSC Hollings Cancer Center offered chances for patients to enter trials of two revolutionary approaches to cancer care.
New Care Delivery Models
Health care resources in South Carolina are concentrated in its metropolitan areas, limiting access for many of its rural residents and threatening to divide its population into health care “haves and have nots.” The state’s burden of chronic diseases, such as stroke, diabetes, and heart disease, is high, with increased complication and mortality rates among rural minority populations. Too often, patients with limited access to care have relied on emergency departments as a last resort, receiving care too late and at a high price tag for the state. South Carolina is responding with an ambitious telehealth initiative that will begin to erase health care inequities by delivering high-quality, affordable care, including preventive care, to all its residents.
Year in Review 2015 New Care
It has been a year of making connections for the South Carolina Telehealth Alliance (SCTA).
Hospital Based Telehealth
Telehealth is enabling hospitals throughout South Carolina to cooperate in unprecedented ways to provide care to all of South Carolina’s residents.
Practice Based Telehealth
Since the founding in 2012 of MUSC Health’s Virtual TeleConsultation program, the demand for nutritional counseling has been palpable.
School Based Telehealth
Nurse practitioner Kelli Garber MSN, APRN, PPCNP-BC, vividly remembers her first telehealth patient from Williamsburg County.
Tomorrow’s clinical innovations will spring from today’s research only if models of discovery evolve to promote translation. The South Carolina Clinical & Translational Research Institute, which received a $23.7 million follow-on grant in 2015 from the NIH’s Clinical and Translational Science Award program, provides research teams with the infrastructure to move innovation into the clinic. Better collaboration between basic scientists and clinicians will also be needed if research is to yield clinically meaningful answers, and multi-institutional collaborations will provide the required diversity of expertise and scope of resources.
New models of funding, including industry/academia partnerships and entrepreneurial ventures, are also necessary. This strategy has worked well for MUSC, which garnered $247 million in research funding in fiscal year 2015, representing a 12 percent increase in overall funding and a 32 percent increase in corporate funding since last year.
Year in Review 2015 Discovery
Drug discovery is at an impasse: nine of ten investigational compounds fail to show efficacy in clinical trials.
A physician/scientist team is designing nanoparticles that smuggle therapies directly to a trouble spot without knocking the rest of the body off balance.
World-class team collaborates to develop a new class of cancer therapeutics.
Teaching a Love of Research
South Carolina has some of the highest cancer health disparities in the nation, according to Marvella E. Ford, Ph.D.